Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 12 04:00PM ET
63.37
Dollar change
-0.78
Percentage change
-1.22
%
Index- P/E- EPS (ttm)-1.11 Insider Own- Shs Outstand30.88M Perf Week-2.53%
Market Cap1.96B Forward P/E- EPS next Y-0.90 Insider Trans- Shs Float- Perf Month-21.91%
Income-33.03M PEG- EPS next Q-0.33 Inst Own0.47% Short Float- Perf Quarter29.80%
Sales0.00M P/S- EPS this Y-0.42% Inst Trans-41.05% Short Ratio3.29 Perf Half Y26.49%
Book/sh3.63 P/B17.44 EPS next Y25.10% ROA-38.10% Short Interest0.23M Perf Year44.68%
Cash/sh3.53 P/C17.95 EPS next 5Y- ROE-40.04% 52W Range31.00 - 86.53 Perf YTD38.51%
Dividend Est.- P/FCF- EPS past 5Y- ROI-29.44% 52W High-26.77% Beta-1.64
Dividend TTM- Quick Ratio24.76 Sales past 5Y0.00% Gross Margin- 52W Low104.39% ATR (14)5.24
Dividend Ex-Date- Current Ratio24.76 EPS Y/Y TTM- Oper. Margin- RSI (14)42.24 Volatility10.83% 7.43%
Employees20 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price86.67
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-14.54% Payout- Rel Volume0.68 Prev Close64.15
Sales Surprise- EPS Surprise2.78% Sales Q/Q- EarningsNov 12 BMO Avg Volume70.64K Price63.37
SMA20-11.99% SMA50-5.97% SMA20024.24% Trades Volume47,716 Change-1.22%
Date Action Analyst Rating Change Price Target Change
Dec-14-23Initiated Maxim Group Buy $60
Jul-28-23Initiated Cantor Fitzgerald Overweight $43
Jul-26-23Initiated SVB Securities Outperform $25
Aug-01-22Initiated H.C. Wainwright Buy $58
Jul-01-22Initiated The Benchmark Company Buy $57
Nov-27-24 03:00AM
Nov-12-24 01:00AM
Nov-05-24 08:00AM
Nov-03-24 04:00PM
Oct-14-24 08:00AM
08:00AM Loading…
Oct-08-24 08:00AM
Sep-26-24 08:51AM
Sep-19-24 02:30AM
Sep-17-24 11:22AM
Sep-10-24 08:00AM
Sep-03-24 08:00AM
Sep-01-24 08:00AM
Aug-09-24 09:52PM
04:30PM
Aug-08-24 08:00AM
07:10PM Loading…
Aug-05-24 07:10PM
Jul-08-24 08:00AM
Jun-12-24 02:55AM
May-14-24 08:00AM
07:53AM
05:17AM
May-13-24 09:50PM
08:00AM
May-08-24 08:00AM
May-06-24 08:15AM
08:00AM
May-01-24 04:15PM
Apr-26-24 06:21AM
Apr-25-24 07:15PM
Apr-10-24 09:55AM
08:00AM Loading…
Mar-22-24 08:00AM
Mar-11-24 10:28PM
09:27PM
Mar-06-24 08:00AM
Mar-04-24 08:00AM
Feb-07-24 08:00AM
Nov-30-23 08:00AM
Nov-20-23 08:00AM
Nov-13-23 08:15PM
Nov-10-23 08:35AM
Nov-07-23 08:00AM
Nov-06-23 04:00PM
08:00AM
Nov-01-23 08:35AM
Oct-31-23 08:35PM
Oct-27-23 08:00AM
Aug-21-23 11:12AM
Aug-08-23 10:17PM
Aug-04-23 08:00AM
Jul-31-23 07:57AM
Jul-27-23 05:00PM
Jul-24-23 06:04AM
Jun-30-23 04:09PM
May-31-23 12:22PM
May-30-23 08:49PM
04:01PM
May-10-23 07:58PM
03:33PM
May-04-23 11:09AM
Apr-25-23 04:30PM
Apr-11-23 09:00AM
Apr-08-23 09:02AM
Mar-31-23 07:03PM
12:57PM
Jan-09-23 08:45AM
Dec-08-22 05:14AM
Nov-18-22 08:00AM
Oct-20-22 08:00AM
Oct-03-22 04:07PM
Oct-01-22 07:03PM
Sep-23-22 08:00AM
Sep-16-22 08:00AM
Aug-22-22 08:00AM
Aug-10-22 09:51PM
Aug-01-22 04:10PM
02:36PM
Jul-30-22 10:47AM
Jul-19-22 04:05PM
May-12-22 04:30PM
May-05-22 08:00AM
May-03-22 04:30PM
06:50AM
Belite Bio, Inc. is a biopharmaceutical company engaged in the research and development of drugs. Its focus is on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wei-Cheng LiawaffiliateNov 20 '24Proposed Sale82.535,999495,097Nov 20 06:25 PM
Nathan MataAffiliateNov 19 '24Proposed Sale82.3430,0002,470,200Nov 19 06:17 PM
Yu-Hsin LinCEO, ChairmanOct 03 '24Proposed Sale48.0040,0001,920,000Oct 03 08:50 PM
Hao-Yuan ChuangOfficer, DirectorOct 03 '24Proposed Sale48.0040,0001,920,000Oct 03 08:48 PM
Wei-Cheng LiawaffiliateSep 20 '24Proposed Sale48.146,500312,910Sep 20 12:40 PM
Wan Shan ChenaffiliateSep 04 '24Proposed Sale48.106,650319,865Sep 04 12:29 PM
Nathan MataaffiliateAug 16 '24Proposed Sale500.0030,00015,000,000Aug 16 06:24 PM
Hao-Yuan ChuangOfficer, DirectorAug 14 '24Proposed Sale49.32100,0004,932,000Aug 14 04:32 PM
Yu-Hsin LinCEO, ChairmanAug 14 '24Proposed Sale49.32100,0004,932,000Aug 14 04:30 PM
Chiu, Ching ChenaffiliateAug 14 '24Proposed Sale49.8434,5681,722,869Aug 14 02:38 PM